BridgeMD
New treatment option for Atrophic Gastritis
Official title SUrveillance of PREMalignant Stomach - Individualized Endoscopic Follow-up
ClinicalTrials.gov ID: NCT04613570
What this study is testing
- What it's testing
- Introduction: Gastric atrophy and intestinal metaplasia are the principal precursors for gastric cancer and, therefore, are considered gastric premalignant conditions. Although current guidelines recommend surveillance of individuals with these conditions, the best method for its identification and staging (histological vs endoscopy) and the best time schedule for follow-up are still controversial.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 45 and older
You may be able to join if
- Patients scheduled for upper GI endoscopy with indication for gastric biopsies, including those with known gastric pathology (e.g. auto-immune...
- Age above 45 years old
You likely can't join if
- History of previous gastrectomy;
- History of endoscopic resection of neoplastic lesion
- History of previous gastric dysplasia (even with no detectable lesion)
- Hereditary syndromes that increase gastric cancer risk (familial adenomatous polyposis; Lynch syndrome)
- Serious comorbidities (ASA 3 or more)
- Medication with anticoagulants
The study team makes the final eligibility decision.
Where it's taking place
- Porto, Portugal
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 45 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Porto, Portugal. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.